Affiliation: University of Cincinnati
- Ghrelin acylation and metabolic controlO Al Massadi
Division of Endocrinology, Department of Medicine, Metabolic Diseases Institute, University of Cincinnati, Cincinnati, OH 45237, USA
Peptides 32:2301-8. 2011..In addition, we summarized the recent literature on the metabolic effects of GOAT specific inhibitors and shared our view on the potential of targeting GOAT for the treatment of metabolic disorders such as obesity and type 2 diabetes...
- Physiology: does gut hormone PYY3-36 decrease food intake in rodents?M Tschop
Department of Psychiatry, University of Cincinnati Genome Research Institute, Cincinnati, Ohio 45237, USA
Nature 430:1 p following 165; discussion 2 p following 165. 2004..The fact that the findings of Batterham et al. cannot easily be replicated calls into question the potential value of an anti-obesity approach that is based on administration of PYY3-36...